In the current study, a novel series of novel benzoxazole-benzamide conjugates linked via a 2-thioacetamido group (1−15) was designed and synthesised as potential anti-cancer agents with probable inhibitory activity on the VEGFR-2 enzyme and on the expression of anti-apoptotic Bcl-2 and Bcl-xL proteins. Here, KDR is linked to cancer.